⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VALN News
Valneva SE American Depositary Shares
Valneva Reports Preliminary Unaudited 2025 Revenue and Cash and Provides 2026 Outlook
globenewswire.com
VALN
Valneva Provides Update on Recommendations for Use of IXCHIQ® in the United Kingdom
globenewswire.com
VALN
Valneva and Instituto Butantan Announce Initiation of a Pilot Vaccination Campaign in Brazil with Single-Shot Chikungunya Vaccine IXCHIQ®
globenewswire.com
VALN
Valneva Provides Update on Chikungunya Vaccine IXCHIQ®
globenewswire.com
VALN
Valneva to Meet with Investors during the J.P. Morgan Healthcare Conference
globenewswire.com
VALN
Valneva Reports Positive Final Phase 2 Antibody Persistence and Safety Results in Children for its Chikungunya Vaccine IXCHIQ®
globenewswire.com
VALN
Valneva to Further Consolidate its Operations in France
globenewswire.com
VALN
Valneva Announces Positive Final Phase 2 Results for Lyme Disease Vaccine Candidate
globenewswire.com
VALN
PFE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN
prnewswire.com
VALN
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN
prnewswire.com
VALN